(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)
Click on image to view larger version.

Fig. 3. Limb development phenotypes resulting from FGF receptor inactivation in
limb mesenchyme with Prx1-Cre. (A) β-galactosidase
staining of Prx1-Cre, R26R forelimb at E9.5. (B-D) Skeletal
preparations of P0 wild-type control (WT), Fgfr1Prx1-Cre
and Fgfr1/2Prx1-Cre mice. (E-L) Appearance (E-H)
and histology (I-L) of E10 forelimb buds of WT, Fgfr1Prx1-Cre,
Fgfr2Prx1-Cre and Fgfr1/2Prx1-Cre embryos
showing a reduced proximodistal axis in Fgfr1/2Prx1-Cre
forelimb buds. (M-P) Phosphohistone H3 (pHH3) immunohistochemistry to
assess proliferation at E10 (M,N) and E10.5 (O,P). (Q-T) Caspase 3
immunohistochemistry used to assess cell death at E10 (Q,R) and E10.5 (S,T).
Note that the region of reduced density of pHH3-positive cells in proximal
mesenchyme of Fgfr1/2Prx1-Cre embryos at E10 (N)
corresponds to the region with increased apoptosis (R). Data are
representative of at least three embryos. Scale bars: in A, I for I-L and M
for M-T, 50 µm.